Black History Month may have passed, but a local museum is continuing to pay homage to historical movements with some new exhibits. The Museums, 3406 Frederick Ave., is working on an interactive Civil ...

(Image Credits: Pixabay) Boehringer Ingelheim’s blockbuster diabetes drug, Empagliflozin, is now off-patent in India, paving the way for domestic drugmakers to launch generic versions.

Missouri Department of Agriculture Director Chris Chinn will be in St. Joseph on Wednesday to attend the St. Joseph Chamber ...

(ST. JOSEPH, Mo.) An agri-business has chosen St. Joseph to be the location for its new 160,000 square foot facility. Nortian ...

Nortian Foodtech, LLC has announced that they will build a new facility in the Stockyards Industrial Park in St. Joseph.

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

Cognizant, as the prime system integrator, began the Boehringer Ingelheim project by codeveloping a program roadmap, agile methodology, and implementation workflow. The overall scope of the project ...

INGELHEIM, Germany and PLEASANTON, Calif., March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer’s One Medicine Platform, ...

Background: The proliferation of inhaler devices has resulted in a confusing number of choices for clinicians who are selecting a delivery device for aerosol therapy. There are advantages and ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.